TABLE 4

Unadjusted predictors of a discordant review article recommendation compared to the contemporary guideline

Predictor variables2001–20112012–2015
Coefficient (95% CI)p-valueCoefficient (95% CI)p-value
NA versus European corresponding author−0.15 (−0.50–0.20)0.41−0.02 (−0.30–0.26)0.88
Year of publication#0.13 (0.07–0.18)<0.00050.20 (0.08–0.33)0.001
MD versus other degree for corresponding author−0.03 (−0.60–0.54)0.920.12 (−0.25–0.50)0.52
Conflict of interest reported0.17 (−0.20–0.54)0.380.02 (−0.32–0.37)0.89
Funding sources reported−0.12 (−0.57–0.33)0.60−0.03 (−0.33–0.27)0.84
Number of IPF publications by corresponding author0.02 (−0.01–0.05)0.250.01 (0–0.18)0.11
Respiratory journal−0.17 (−0.55–0.21)0.38−0.32 (−0.58– −0.06)0.02
Journal impact factor, available−0.34 (−0.71–0.04)0.08−0.07 (−0.35–0.20)0.60
Journal impact factor, raw value0.01 (−0.03–0.05)0.530.04 (0.01–0.08)0.02
Cited 2000 guideline0.26 (−0.15–0.67)0.210.46 (0.18–0.74)0.001
Cited 2011 guideline−0.21 (−0.52–0.08)0.15
DISCERN score0.12 (−0.12–0.37)0.330.11 (−0.07–0.29)0.23

All coefficients are based on a Poisson analysis. NA: North American; MD: medical doctor; IPF: idiopathic pulmonary fibrosis. #: independent predictor of discordant recommendation for 2001–2011 and 2012–2015; : per 10-unit change in DISCERN score.